Biopharma · FDA Approvals · Stock

IX ORIX

ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee bu…

Assets on file: Cecolin 9

Start live analysis of IX Run 8-agent AI analysis All sector events →

Catalyst calendar

Dated catalysts for IX, including recently decided ones.

Nothing scheduled in this window.

Recent first-hand events

Every first-hand event for IX, newest first.

Instant stream — events appear as soon as they are filed.

Decision-gradeMaterialNotableMinor

Oct 27, 2026

02:20 PM

IXORIX

Xiamen Innovax presents Cecolin 9 interim data at IPVS 2026

Xiamen Innovax presented Month 6 interim immunogenicity and safety data from the Phase 3 SHINE I study comparing single-dose Cecolin 9 to Gardasil 9. Final data from the trial are expected in 2028.

Conference presentationCompany press release3 updates